DEC 08, 2017 7:07 AM PST

Drug that Fights Alcoholism Also Fights Cancer

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

The drug that helps alcoholics kill their vice can also help kill cancer cells. And in a new study, researchers uncover the mechanism behind the anticancer effects of this anti-drinking drug, renewing the potential that this drug may someday be an option for cancer patients.

Known as disulfiram (trade name Antabuse), this drug is a potent inhibitor of acetaldehyde dehydrogenase, the enzyme responsible for metabolizing alcohol in the liver. When disulfiram is taken, any exposure to alcohol induces severe “hangover” symptoms, including flushing, throbbing headache, nausea, “copious vomiting,” and a slew of other unpleasant side effects, according to the manufacturer. So while disulfiram can’t be considered an antidote to alcoholism, it makes drinking so unpleasant as to help the person break their alcohol addiction.

But disulfiram has another power, killing cancer. Researchers have known this secondary effect since the 1970s – some studies have shown that disulfiram kills cancer in cells and in animal models. But how does this anti-drinking drug exert anti-cancer effects?

Researchers from the Danish Cancer Society Research Center in Copenhagen decided to pursue this hopeful path. They aimed find a link between disulfiram and survival in cancer patients. If indeed there is a link, they aimed to uncover the mechanisms behind disulfiram’s anticancer properties.

To answer their first aim, the team collected and analyzed data from over 3,000 Danish people who have been diagnosed with cancer. Mainly, they compared the survival of patients who took disulfiram after diagnosis versus those who stopped using the drug.

The team found an astonishing correlation: those who were on disulfiram after their cancer diagnosis had a 34 percent reduction in the risk of death from cancer, as compared to those who weren’t taking disulfiram. This protection seemingly applied to those suffering from colon, prostate, and breast cancers.

Taking the results even further, the team investigated disulfiram’s mechanisms in cancer cells and later in a mouse model. They landed on a key molecule, NPL4–p97, which promotes tumor growth. As it turns out, disulfiram immobilizes this protein, which consequently suppresses tumor growth.

“This paper solves a puzzle that has persisted in cancer research for decades,” said Michele Pagano, a cancer biologist at New York University who was not involved in the study.

Because disulfiram is an old drug, the road towards repurposing this drug for cancer treatment could be significantly shortened. And while pharmaceutical companies won’t exactly be clamoring for dibs (no patent protection, little financial incentive), the drug still holds a vast appeal for researchers, doctors, and cancer patients.

"Our results help to explain the anticancer activity of the alcohol-abuse drug disulfiram," said Jiri Bartek, the study’s senior author. "From a broader perspective, our study illustrates the potential of multifaceted approaches to drug repurposing, providing novel mechanistic insights, identification of new cancer-relevant targets, and encouragement for further clinical trials."

"[Disulfiram is] an old, safe, and public domain drug that might help to save lives of patients with cancer worldwide,” the team concluded.

Additional sources: Miami Herald, NatureMNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
FEB 01, 2021
Cancer
Nanoparticle drug delivery to treat pancreatic cancer
FEB 01, 2021
Nanoparticle drug delivery to treat pancreatic cancer
Research published last month in the journal Molecular Pharmaceutics details a new mechanism for delivering pancreatic c ...
FEB 18, 2021
Cell & Molecular Biology
Inhibition of a Specific Enzyme Could be a Way to Treat Glioblastoma
FEB 18, 2021
Inhibition of a Specific Enzyme Could be a Way to Treat Glioblastoma
Researchers may have identified a new treatment target for a deadly form of brain cancer. Inhibiting an enzyme called PR ...
MAR 09, 2021
Cancer
Chinese Americans face high barriers for cancer screening
MAR 09, 2021
Chinese Americans face high barriers for cancer screening
A study recently published in the Asian Pacific Journal of Cancer Prevention reports that Chinese Americans are fac ...
MAR 22, 2021
Cancer
Can we use our own bacteria to fight cancer?
MAR 22, 2021
Can we use our own bacteria to fight cancer?
New research highlighted recently in Nature explores the ways that bacteria in tumors could be targeted to trigger immun ...
MAR 12, 2021
Drug Discovery & Development
Drug Starves Melanoma Tumors
MAR 12, 2021
Drug Starves Melanoma Tumors
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
Loading Comments...